MedTrace Logo

Characterization of the DELPhI System in Assessing Brain's Functionality in Different Neurological Disorders

NCT03832413 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 193

Last updated 2022-02-16

No results posted yet for this study

Summary

We use Transcranial magnetic stimulation (TMS), combined with simultaneous registration of electroencephalograph (EEG),for examining human cortical functionality. TMS-EEG is a noninvasive brain stimulation method that allows to study human cortical function in vivo. EEG provides an opportunity to directly measure the cerebral response to TMS, measuring the cortical TMS Evoked potential (TEP). In this study we measure TEPs, in a wide variety of neurological conditions and healthy as a measure of cerebral reactivity across wide areas of neocortex.

Conditions

Interventions

DIAGNOSTIC_TEST

DELPhI (TMS-EEG analysis)

We perform an evaluation not an intervention. the DELPhI evaluation comprises of an automated analysis to EEG data recorded during TMS (Transcranial Magnetic Stimulation) to the M1L (Primary motor cortex).

Sponsors & Collaborators

  • QuantalX Neuroscience

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-04-23
Primary Completion
2022-02-14
Completion
2022-02-14
FDA Device
Yes

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03832413 on ClinicalTrials.gov